Funding backs a human-first approach to drug safety and efficacy, reducing reliance on animal testing and accelerating ...

Kite, a Gilead Company , presented a new analysis today demonstrating that second-line Yescarta® (axicabtagene ciloleucel) therapy offers consistent benefits in patients with relapsed/refractory large ...

Detailed price information for Bionano Genomics Inc (BNGO-Q) from The Globe and Mail including charting and trades.

Human researchers outperformed large language models across all major stages of systematic review preparation, particularly ...

When 24-year-old Jenna Walliser boarded a plane from Canada to Western Australia last October, she knew she was signing up ...